Genetic polymorphisms in the cag pathogenicity island of Helicobacter pylori and risk of stomach cancer and high‐grade premalignant gastric lesions
暂无分享,去创建一个
N. Muñoz | E. Kasamatsu | C. Rizzato | F. Canzian | A. Méndez-Tenorio | Wei Chen | I. Kato | M. Bravo | J. Torres | M. Camorlinga-Ponce | J. Vivas | E. Trujillo | L. Flores‐Luna | O. Obazee | A. Stein | H. Jang | Ofure Obazee
[1] C. Rizzato,et al. Variations in cag pathogenicity island genes of Helicobacter pylori from Latin American groups may influence neoplastic progression to gastric cancer , 2020, Scientific Reports.
[2] M. Zali,et al. Genetic diversity and amino acid sequence polymorphism in Helicobacter pylori CagL hypervariable motif and its association with virulence markers and gastroduodenal diseases , 2019, Cancer medicine.
[3] Carlos A Castañón-Sánchez,et al. CagL polymorphisms D58/K59 are predominant in Helicobacter pylori strains isolated from Mexican patients with chronic gastritis , 2019, Gut Pathogens.
[4] D M Parkin,et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods , 2018, International journal of cancer.
[5] R. Alizadeh-Navaei,et al. Systematic review with meta‐analysis: the worldwide prevalence of Helicobacter pylori infection , 2018, Alimentary pharmacology & therapeutics.
[6] H. Nouri,et al. Helicobacter pylori cagL amino acid polymorphism D58E59 pave the way toward peptic ulcer disease while N58E59 is associated with gastric cancer in north of Iran. , 2017, Microbial pathogenesis.
[7] T. Azuma,et al. Genetic variants of Helicobacter pylori type IV secretion system components CagL and CagI and their association with clinical outcomes , 2017, Gut Pathogens.
[8] M. Hatakeyama,et al. Sequence Polymorphism and Intrinsic Structural Disorder as Related to Pathobiological Performance of the Helicobacter pylori CagA Oncoprotein , 2017, Toxins.
[9] D. Falush,et al. Correction: Rapid evolution of distinct Helicobacter pylori subpopulations in the Americas , 2017, PLoS genetics.
[10] Yuan Yuan,et al. Association of CagA EPIYA-D or EPIYA-C phosphorylation sites with peptic ulcer and gastric cancer risks , 2017, Medicine.
[11] C. Rizzato,et al. Whole Genome Sequence and Phylogenetic Analysis Show Helicobacter pylori Strains from Latin America Have Followed a Unique Evolution Pathway , 2017, Front. Cell. Infect. Microbiol..
[12] D. Falush,et al. Rapid evolution of distinct Helicobacter pylori subpopulations in the Americas , 2016, bioRxiv.
[13] T. Kwok,et al. Helicobacter pylori CagL Hypervariable Motif: A Global Analysis of Geographical Diversity and Association With Gastric Cancer. , 2016, The Journal of infectious diseases.
[14] T. Kwok,et al. Preservation of Helicobacter pylori CagA Translocation and Host Cell Proinflammatory Responses in the Face of CagL Hypervariability at Amino Acid Residues 58/59 , 2015, PloS one.
[15] C. Maldonado-Bernal,et al. Polymorphisms in TLR9 but not in TLR5 increase the risk for duodenal ulcer and alter cytokine expression in the gastric mucosa , 2015, Innate immunity.
[16] Jin Myung Choi,et al. Crystal structure of CagL from Helicobacter pylori K74 strain. , 2015, Biochemical and biophysical research communications.
[17] K. Diederichs,et al. Integrin Engagement by the Helical RGD Motif of the Helicobacter pylori CagL Protein Is Regulated by pH-induced Displacement of a Neighboring Helix* , 2015, The Journal of Biological Chemistry.
[18] S. Backert,et al. Structure of a three-dimensional domain-swapped dimer of the Helicobacter pylori type IV secretion system pilus protein CagL. , 2014, Acta crystallographica. Section D, Biological crystallography.
[19] B. Peleteiro,et al. Prevalence of Helicobacter pylori Infection Worldwide: A Systematic Review of Studies with National Coverage , 2014, Digestive Diseases and Sciences.
[20] M. Shariq,et al. Cag Type IV Secretion System: CagI Independent Bacterial Surface Localization of CagA , 2013, PloS one.
[21] J. Gaddy,et al. Functional Plasticity in the Type IV Secretion System of Helicobacter pylori , 2013, PLoS pathogens.
[22] D. Morgan,et al. Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701) , 2013, Cancer Causes & Control.
[23] E. Kasamatsu,et al. The utility of serologic tests as biomarkers for Helicobacter pylori-associated precancerous lesions and gastric cancer varies between Latin American countries , 2013, Cancer Causes & Control.
[24] F. Inagaki,et al. Tertiary structure-function analysis reveals the pathogenic signaling potentiation mechanism of Helicobacter pylori oncogenic effector CagA. , 2012, Cell host & microbe.
[25] Jing Hu,et al. SIFT web server: predicting effects of amino acid substitutions on proteins , 2012, Nucleic Acids Res..
[26] G. Rieder,et al. Helicobacter pylori CagL dependent induction of gastrin expression via a novel αvβ5-integrin–integrin linked kinase signalling complex , 2012, Gut.
[27] M. Plummer,et al. Variations in Helicobacter pylori Cytotoxin-Associated Genes and Their Influence in Progression to Gastric Cancer: Implications for Prevention , 2012, PloS one.
[28] Yi-Chun Yeh,et al. H. pylori cagL amino acid sequence polymorphism Y58E59 induces a corpus shift of gastric integrin α5β1 related with gastric carcinogenesis , 2011, Molecular carcinogenesis.
[29] J. C. Robayo,et al. Asociación de los polimorfismos IL-1B-511 e IL-1RN y Helicobacter pylori CagA positivo con cáncer gástrico en una zona de riesgo alto en Colombia , 2011 .
[30] P. Christie,et al. Evidence for VirB4-Mediated Dislocation of Membrane-Integrated VirB2 Pilin during Biogenesis of the Agrobacterium VirB/VirD4 Type IV Secretion System , 2010, Journal of bacteriology.
[31] C. Maldonado-Bernal,et al. TLR4 single-nucleotide polymorphisms alter mucosal cytokine and chemokine patterns in Mexican patients with Helicobacter pylori-associated gastroduodenal diseases. , 2008, Clinical immunology.
[32] M. Piazuelo,et al. Natural history of Helicobacter pylori infection. , 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[33] M. Plummer,et al. Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions. , 2007, Journal of the National Cancer Institute.
[34] Stef van Buuren,et al. Multiple imputation of discrete and continuous data by fully conditional specification , 2007 .
[35] J. Puente,et al. Heterogeneity in the Activity of Mexican Helicobacter pylori Strains in Gastric Epithelial Cells and Its Association with Diversity in the cagA Gene , 2007, Infection and Immunity.
[36] M. Hatakeyama. Helicobacter pylori CagA—a bacterial intruder conspiring gastric carcinogenesis , 2006, International journal of cancer.
[37] M. Achtman,et al. Characterization of the Pilin Ortholog of the Helicobacter pylori Type IV cag Pathogenicity Apparatus, a Surface-Associated Protein Expressed during Infection , 2006, Journal of bacteriology.
[38] D. Parkin,et al. The global health burden of infection‐associated cancers in the year 2002 , 2006, International journal of cancer.
[39] S. Ahrné,et al. Multiple displacement amplification of DNA from human colon and rectum biopsies: bacterial profiling and identification of Helicobacter pylori-DNA by means of 16S rDNA-based TTGE and pyrosequencing analysis. , 2005, Journal of microbiological methods.
[40] M. Plummer,et al. Environmental factors in Helicobacter pylori-related gastric precancerous lesions in Venezuela. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[41] Takeshi Azuma,et al. SHP-2 Tyrosine Phosphatase as an Intracellular Target of Helicobacter pylori CagA Protein , 2001, Science.
[42] N. Sasaki,et al. Helicobacter pylori infection and the development of gastric cancer. , 2001, The New England journal of medicine.
[43] A. Helicobacter,et al. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts , 2001, Gut.
[44] P. Sharp,et al. Absence of translationally selected synonymous codon usage bias in Helicobacter pylori. , 2000, Microbiology.
[45] M. Borodovsky,et al. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[46] L. Peterson,et al. Development of a rapid and efficient restriction endonuclease analysis typing system for Clostridium difficile and correlation with other typing systems , 1993, Journal of clinical microbiology.
[47] M. Bravo,et al. [Association of interleukin-1 genetic polymorphism and CagA positive Helicobacter pylori with gastric cancer in Colombia]. , 2011, Revista medica de Chile.
[48] S. Shao,et al. Characterization of peptidoglycan hydrolase in Cag pathogenicity island of Helicobacter pylori , 2010, Molecular Biology Reports.
[50] N. Muñoz,et al. Prevalence of precancerous lesions of the stomach in Venezuela. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.